Mental health company Talkspace has purchased Wisdo Health, an AI-powered platform for social health and peer support. The post Talkspace Acquires Peer Support Platform Wisdo Health appeared first on MedCity News.
En lo que se ha convertido en un patrón de diseminación de desinformación sobre las vacunas, el Departamento de Salud de Florida está aconsejando a sus residentes mayores y a otros en mayor riesgo de covid-19 que eviten la mayoría de los refuerzos, asegurando que son potencialmente peligrosos. Clínicos y científicos denuncian este mensaje como…
As trends around expanded decision-making ecosystems, consumer empowerment, data and intelligence, and economic uncertainty become everyday realities, the need for medical device companies to rethink and expand their business models becomes more urgent. The post From Products to Services: How Medical Device Companies Miss $100M+ Opportunities appeared first on MedCity News.
By DAVID INTROCASO After having worked in DC for sixteen years, in 2013 I created The Healthcare Policy Podcast. The title was in part intended to be sarcastic because healthcare policymaking in DC is very narrowly drawn. Consequently, healthcare delivery is excessively commodified, reductionistic and financialized or in sum anachronistic and ironically lacking purchase. If the…
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California. The post FDA Approves First At-Home Cervical Cancer Test appeared first on MedCity News.
Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics. The post Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect appeared first on MedCity News.
HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight the shifting landscape of healthcare innovation in many different settings. Register today! The post 12 Compelling Sessions to Check Out at HLTH 2024 appeared first on MedCity News.
Results from the Phase 3 DREAMM-7 study show GSK drug Blenrep is helping multiple myeloma patients live longer compared to treatment with blockbuster Johnson & Johnson drug Darzalex. The data, presented Monday during the annual meeting of the American Society of Hematology, are part of a submission now under FDA review that could lead to…
At Forbes Healthcare Summit, Epic CEO Judy Faulkner explained why the company’s long-protected independence and unconventional management approach have been central to its dominance as an EHR vendor. Now, she says the company’s future will depends on how it uses its massive data stores to support AI-powered clinical decisions. The post Why Epic’s Judy Faulkner…
A new survey from Mercer found that 51% of large employers said they are likely or very likely to make health benefit changes that would shift more costs to employees. The post Employers Will Likely Reduce Health Benefits in 2026, New Mercer Survey Reveals appeared first on MedCity News.